Midgard Science

wuxiXDC

Singapore, Singapore wuxixdc.com

From their website, Nov 2026

Work here? Claim this listing

About

WuXi XDC is a CRDMO focused on discovery, development, and cGMP manufacturing for ADCs and other bioconjugates. It serves global biopharmaceutical partners from sites in Wuxi, Shanghai, Changzhou, and Singapore.

Services

  • Bioconjugation Discovery

    Generates, engineers, evaluates, and optimizes ADCs and other bioconjugates to identify lead candidates.

    Assays & in vitro testing

  • Bioconjugation Process Development

    Provides process development, scale-up, and tech-transfer support for ADCs, bioconjugates, and diagnostic or imaging reagents.

  • Analytical Development

    Provides analytical development services for bioconjugates.

    Assays & in vitro testing

  • Formulation and DP Development

    Designs liquid, frozen, or lyophilized dosage forms for bioconjugates and related advanced molecular complexes.

  • GMP mAb Intermediate and Conjugation Manufacturing

    Manufactures mAb intermediates and ADC drug substance under GMP conditions.

    CDMO: development & manufacturing

  • GMP Formulation, Fill and Lyophilization

    Provides GMP drug product formulation, filling, and lyophilization services for bioconjugates.

    CDMO: development & manufacturing

  • Payload and Linker R&D and Manufacturing

    Develops and manufactures payload-linker components for bioconjugates.

  • Ready-Made Payloads & Linkers

    Offers ready-made payloads and linkers for bioconjugate development and manufacturing.

Capabilities

Assays and studies
ADCs · Process development · Lyophilization · Analytical development · Antibodies · Bispecifics · Oligonucleotides · QC release testing · Stability testing
Scale and capacity
5 L to 500 L single-use reactor systems · 50 L to 2,000 L per batch · Up to 2 x 2,000 L bioreactors · 3 million vials per year · 5 million doses of bioconjugate drug products per year
Therapeutic areas
Cancer · Autoimmune diseases

Instruments and platforms

  • Lyophilizer 1×5 m2
  • Lyophilizer 1×20 m2

Modalities and species

Modalities
Small molecule · Antibody · Bispecific · ADC · Oligonucleotide · Recombinant protein

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

Company

Type
CRDMO
Team
Over 2000 skilled employees

Locations

Based in
Singapore, Singapore
Sites
Wuxi, China · Shanghai, China · Changzhou, China · Singapore, Singapore
Serves
global

Similar labs

Work here? Claim this listing